+499.5%
MRNA vs RF
+16.9%
+482.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | RF | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.1% | -2.2% | -2.3% |
| 7D | +5.5% | +1.3% | +4.2% | +6.7% |
| 30D | +158.7% | -3.6% | +162.3% | +157.3% |
| 3M | +182.1% | +8.1% | +174.0% | +167.7% |
| 6M | +151.8% | +11.5% | +140.3% | +133.4% |
| YTD | +393.6% | +15.6% | +378.0% | +338.9% |
| 1Y | +499.5% | +15.7% | +483.8% | +366.5% |
| All | +499.5% | +16.9% | +482.5% | +366.5% |
Cumulative growth
Daily Returns
Daily percentage return beside RF.
Daily Out/Under-Performance
Portfolio return minus RF return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RF return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded RF wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling